Product Description: CDK2-IN-13 (Compound 15) is a CDK2 inhibitor with an IC50 of 12 µM. CDK2-IN-13 can be used in research of cancer[1].
Applications: Cancer-Kinase/protease
Formula: C13H12ClN5
References: [1]Havlícek L, et al. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem. 1997 Feb 14;40(4):408-12.
CAS Number: 101622-53-1
Molecular Weight: 273.727
Compound Purity: 98.20
Research Area: Cancer
Solubility: DMSO : 11.11 mg/mL (ultrasonic;warming;adjust pH to 11 with NaOH;heat to 60°C)